| scholarly article | Q13442814 |
| P2093 | author name string | Michael Doumas | |
| Dimitrios Patoulias | |||
| Konstantinos Imprialos | |||
| Konstantinos Stavropoulos | |||
| P2860 | cites work | Leptin and incident cardiovascular disease: the Multi-ethnic Study of Atherosclerosis (MESA). | Q35091303 |
| Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis | Q36302302 | ||
| Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States | Q36756206 | ||
| Leptin and coronary heart disease: a systematic review and meta-analysis. | Q38188131 | ||
| Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases. | Q39420619 | ||
| Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis. | Q39745120 | ||
| Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention | Q45067817 | ||
| The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study | Q90692081 | ||
| Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients | Q91583335 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | metabolic dysfunction–associated steatotic liver disease | Q1546498 |
| cardiovascular disease | Q389735 | ||
| non-alcoholic fatty liver | Q66299798 | ||
| P304 | page(s) | 331-332 | |
| P577 | publication date | 2019-05-30 | |
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease | |
| P478 | volume | 25 |
Search more.